A methyl-to-acetyl switch in H3K27 drives metabolic reprogramming and resistance to BRAFV600E inhibition in melanoma
The BRAFV600E pathway and epigenetic machinery are central to melanoma pathogenesis. However, how these processes intersect and their potential for synthetic lethality remains unclear. Here, we identified a BRAFV600E-driven epigenetic mechanism in melanoma that involves a H3K27 methylation-to-acetyl...
Saved in:
| Main Authors: | Jiang Zhou, Xinxin Chai, Yi Zhu, Zhi Huang, Tingting Lin, Zhen Hu, Guangdi Chen, Chi Luo, Rutao Cui, Jinghao Sheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558625001022 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRAFV600E‐PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterization
by: Solomon O. Alhassan, et al.
Published: (2025-03-01) -
Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c‐Jun pathway in adaptive resistance to drug‐induced apoptosis
by: Mohammad Fallahi‐Sichani, et al.
Published: (2015-03-01) -
Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
by: Yilamujiang Ainiwan, et al.
Published: (2025-03-01) -
Cutaneous metastasis of cecum cancer with MSI-high and BRAFV600E mutation: a case report
by: Kosuke Yunoki, et al.
Published: (2021-08-01) -
Management of asynchronous multifocal adult glioblastoma with loss of BRAFV600E -mutant clonality: a case report
by: Hannah Haile, et al.
Published: (2025-01-01)